The hormone therapy industry's most comprehensive guide to directory-based patient acquisition — built for providers who want to understand the real math behind patient acquisition costs, compliance exposure, and ROI benchmarks across TRT, peptide, and GLP-1 markets.
12 Chapters — 180+ Pages
From market sizing and CAC modeling to compliance frameworks and ROI benchmarks — every chapter is built from real directory data.